ULK1 and metabolic dysfunction-associated steatohepatitis: In conclusion, our study found that gemigliptin effectively ameliorates hepatic steatosis, inflammation, and fibrosis in an MCD diet–induced NASH model mice by enhancing autophagy through an increase in ULK1 expression.